In their Covid-19 Lecture, Prof. Clarissa Prazeres da Costa and Dr. Nina Wantia talk about local and national infection prevention strategies.
In their Covid-19 Lecture, Prof. Clarissa Prazeres da Costa and Dr. Nina Wantia talk about local and national infection prevention strategies.
Image: ediundsepp

Interview with Prof. Clarissa Prazeres da Costa and Dr. Nina Wantia on their Covid-19 Lecture"Our hospital prepared very early"

In their Covid-19 Lecture, Prof. Clarissa Prazeres da Costa and Dr. Nina Wantia of the Institute of Medical Microbiology, Immunology and Hygiene show how hospitals had to act quickly and extensively to protect patients and staff from infection with Sars-CoV2. The two also look back at past pandemics and discuss how looking back at the past helps to better master a current situation.

What were the main measures hospitals relied on in the Corona pandemic to protect patients and staff?

Prof. Prazeres da Costa:
The main pillars of the strategy were spatial and organizational measures, and the use of personal protective equipment for hospital staff. This was supplemented by a comprehensive testing strategy: Sars-CoV2 infected patients had to be identified as quickly as possible to prevent infection. We also implemented a local vaccination strategy with the aim of quickly protecting particularly vulnerable groups among our employees.
 

How did you meet this challenge at Klinikum rechts der Isar in particular?
 

Prof. Prazeres da Costa: Our hospital prepared very early and put together an interdisciplinary team of experts. In the first few months of the crisis, these experts met every day, because at that time it was completely unclear what we were facing. It had to be possible to react on a daily basis. It was necessary to discuss and implement the new scientific publications that appeared every day, as well as the recommendations of the Robert Koch Institute and the health authorities. In our presentation, we report on some highlights from the daily routine, especially from the perspective of prevention and hospital hygiene. But we also talk about the new networks of university medicine (NUM) that have emerged in the meantime and about research projects in this field.
Dr. Wantia: Of course, there have always been difficulties in implementing measures. Communicating the state of knowledge and the measures derived from it, as well as training all affected employees, were major challenges. Especially at the beginning of the pandemic, this was made even more difficult by supply bottlenecks, for example of protective equipment and ventilation supplies. In short, the fact that all employees at the hospital always knew what to do in which situation - that was a major joint achievement.

Sometimes, looking back at the past helps to better master a current situation. Are such comparisons also worthwhile with regard to pandemic pathogens?

Prof. Prazeres da Costa:
This is an enormously relevant and important question. In the lecture, we therefore also take a historical look at other pandemics, such as those caused by influenza: the Spanish flu in 1918/19 and the swine flu in 2009. We will also assess the relevance of the SARS CoV-1 and MERS outbreaks. For example, we will discuss the intriguing question of why there was not a pandemic with the very closely related pathogen SARS-CoV-1 in 2003. We will talk about what role the so-called reproductive number, virus shedding and mobility played in this. Furthermore, about what measures were taken in different countries, which of them were successful, and which were not. Our aim is to show how important it is to work through the current pandemic as well - especially since it is highly likely that this will not be the last.

COVID-19 Lectures: Infektionsprävention - lokale und nationale Strategien (in German language)

More information:

Technical University of Munich

Corporate Communications Center Corporate Communications Center
a.schmidt(at)tum.de

Related articles at www.tum.de

Co-author Prof. Burkhard Rost in the Department of Informatics at the Technical University of Munich.

The proteins of Covid-19

The proteins of SARS-CoV-2 play key roles in how the virus manages to evade immune defense and replicate itself in patients’ cells. An international research team – with significant contribution from the Technical…

Researcher works in front of a monitor

New approach identifies T cells in Covid-19 patients

T cells play a decisive role in fighting the coronavirus and preventing infected individuals from becoming seriously ill. They identify and fight the virus directly within the infected cells. A team of researchers working…

Woman is getting vaccinated.

Mix-and-match vaccines against Covid-19 tested

People under the age of 60 who initially received a vaccine from AstraZeneca should be given an mRNA vaccine at their second appointment. This is recommended by the German Standing Committee on Vaccination. However, up…